A phase II, multicenter, single-arm study of Induction therapy with LDK378 followed by surgery in patients with ALK fusion-positive Stage II/III non-small cell lung cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2018
At a glance
- Drugs Ceritinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 23 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 07 Aug 2015 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan.
- 02 Jul 2015 New trial record